Research Education

PerformanceLabsUK supplies independently tested research reference materials for in vitro laboratory and scientific research use only, not for human or veterinary use.

Thymosin Beta-4 (TB-500) in Tissue Repair Research

Compound Research

This page summarises findings from published academic literature. It does not describe or endorse use in humans or animals.

Thymosin Beta-4, often referenced by the synthetic fragment name TB-500, is a naturally occurring peptide studied for its role in actin regulation and tissue repair pathways. This page gives a general overview of what published research examines, for research reference purposes only.

What Is Thymosin Beta-4?

Thymosin Beta-4 is a naturally occurring peptide found in most human and animal cells, studied primarily for its role in binding actin, a protein central to cell structure and movement. TB-500 refers to a synthetic fragment studied as a stable research analogue of the naturally occurring peptide.

Areas of Published Research

Published research on Thymosin Beta-4 has examined actin regulation at a cellular level, cell migration studies, and tissue repair pathway research, primarily using in vitro cell-based models and in vivo animal models. Research in this area often focuses on how actin-binding activity relates to broader cellular repair mechanisms.

Actin Regulation as a Research Focus

Actin is a structural protein involved in cell shape and movement, and Thymosin Beta-4's actin-binding property is central to why it is studied. Researchers examine how this binding activity relates to cell migration and tissue-level repair processes observed in laboratory models.

Comparing Research Focus Areas

Research area	What published literature examines
Actin regulation	Binding activity and its effect on cell structure
Cell migration	How actin regulation relates to cell movement in culture
Tissue repair pathways	Cellular-level processes studied in animal models

Frequently asked questions

Is TB-500 the same as Thymosin Beta-4?

TB-500 is generally used in research literature to refer to a synthetic fragment studied as an analogue of the naturally occurring Thymosin Beta-4 peptide. Both terms relate to the same broader area of actin-binding research.

Is this compound tested before dispatch?

Yes. Every batch is independently tested and issued with a batch-specific Certificate of Analysis before dispatch.

Is this compound intended for human or animal use?

No. All compounds discussed on this site are supplied strictly for in vitro laboratory research use only, and are not intended for human or animal administration.

Where can I find the Certificate of Analysis?

Batch-specific Certificates of Analysis are published in the PerformanceLabsUK COA library, referenced against the batch number shown on the product page.

Does this page constitute medical advice?

No. This page is provided for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional for any medical concern.

Research content only. PerformanceLabsUK Ltd, company number SC883220, registered in Scotland.